Erianin serves as an NFATc1 inhibitor to prevent breast cancer-induced osteoclastogenesis and bone destruction
Article in Journal of Advanced Research (March 2024)
The most recent citing publications are shown below. View all 349 publications that cite this research output on Dimensions.
Article in Journal of Advanced Research (March 2024)
Article in Nutrition & Metabolism (January 2024)
Article in Journal of Biological Chemistry (December 2023)